Toxicological Research

Korean Society of Toxicology & Korea Environmental Mutagen Society (한국독성학회)
권호 표지
DOI QR코드

DOI QR Code

Inhibition of Dermatitis Development by Sopungsan in Nc/Nga Mice

  • Published : 2008.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Sopungsan (SS) is a traditional Korean decoction used for the treatment of dermatitis. The aim of this study is to confirm whether or not SS has a preventive effect on the development of atopic dermatitis in dinitrochlorobenzene-applied Nc/Nga mice. SS was administered orally to Nc/Nga mice, which led to the remarkable suppression of the development of dermatitis, as determined by a histological examination and the serum IgE levels. Moreover, SS inhibited the production of thymus- and activation-regulated chemokine (TARC) and its mRNA expression in a keratinocyte cell line, HaCaT, which had been stimulated with tumor necrosis factor-${\alpha}$ (TNF-${\alpha}$) and interferon-${\gamma}$ (IFN-${\gamma}$). Activation of the nuclear factor-${\kappa}B$ (NF-${\kappa}B$) or activator protein-1 (AP-1) is one of key steps in the signaling pathways mediating induction of TARC. In this study, SS selectively suppressed NF-${\kappa}B$ activation which may be essential for TARC expression in $TNF-{\alpha}/IFN-{\gamma}$ treated keratinocytes. The inhibitory effect of SS on NF-${\kappa}B$ activation and TARC production might be associated with the anti-dermatitic effects of SS.

Keywords

References

  1. Berin, M.C., Eckmann, L., Broide, D.H. and Kagnoff, M.F. (2001). Regulated production of the T helper 2-type T-cell chemoattractant TARC by human bronchial epithelial cells in vitro and in human lung xenografts. Am. J. Resp. Cell. Mol. Biol., 24, 382-389 https://doi.org/10.1165/ajrcmb.24.4.4360
  2. Furukawa, H., Takahashi, M., Nakamura, K. and Kaneko, F. (2004). Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis. J. Dermat. Sci., 36, 165-172 https://doi.org/10.1016/j.jdermsci.2004.09.001
  3. Hanifin, J. and Rajka, G. (1980). Diagnostic features of atopic dermatitis. Acta. Dermato-Venereologica, 92, 44-47
  4. Imai, T., Baba, M., Nishimura, M., Kakizaki, M., Takagi, S. and Yoshie, O. (1997). The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J. Biol. Chem., 272, 15036-15042 https://doi.org/10.1074/jbc.272.23.15036
  5. Kawasaki, S., Takizawa, H., Yoneyama, H., Nakayama, T., Fujisawa, R., Izumizaki, M., Imai, T., Yoshie, O., Homma, I., Yamamoto, K. and Matsushima, K. (2001). Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice. J. Immunol., 166, 2055-2062 https://doi.org/10.4049/jimmunol.166.3.2055
  6. Komine, M., Kakinuma, T., Kagami, S., Hanakawa, Y., Hashimoto, K. and Tamaki, K. (2005). Mechanism of thymusand activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin. J. Invest. Dermatol., 125, 491-498 https://doi.org/10.1111/j.0022-202X.2005.23840.x
  7. Kotani, M., Matsumoto, M., Fujita, A., Higa, S., Wang, W., Suemura, M., Kishimoto, T. and Tanaka, T. (2000). Persimmon leaf extract and astragalin inhibit development of dermatitis and IgE elevation in NC/Nga mice. J. Allerg. Clin. Immunol., 106, 159-166 https://doi.org/10.1067/mai.2000.107194
  8. Lee, J.Y., Woo, E.R. and Kang, K.W. (2005). Inhibition of lipopolysaccharide-inducible nitric oxide synthase expression by acteoside through blocking of AP-1 activation. J. Ethnopharmacol., 97, 561-566 https://doi.org/10.1016/j.jep.2005.01.005
  9. Leung, D.Y. (1997). Atopic dermatitis: immunobiology and treatment with immune modulators. Clin. Exp. Immunol., 107, 25-30
  10. Matsuda, H., Watanabe, N., Geba, G.P., Sperl, J., Tsudzuki, M., Hiroi, J., Matsumoto, M., Ushio, H., Saito, S., Askenase, P.W. and Ra, C. (1997). Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int. Immunol., 9, 461-466 https://doi.org/10.1093/intimm/9.3.461
  11. Nakayama, T., Hieshima, K., Nagakubo, D., Sato, E., Nakayama, M., Kawa, K. and Yoshie, O. (2004). Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus. J. Virol., 78, 1665-1674 https://doi.org/10.1128/JVI.78.4.1665-1674.2004
  12. Park, S.J., Lee, S.G., Baek, J.H., Byun, S.H. and Kim, S.C. (2006). Effect of sopung-san on contact hypersensitivity induced by repeat elicitation of DNCB. Kor. J. Orient. Physiol. Pathol., 20, 623-628
  13. Sandoval-Lopez, G. and Teran, L.M. (2001). TARC: novel mediator of allergic inflammation. Clin. Exp. Allerg., 31, 1809-1812 https://doi.org/10.1046/j.1365-2222.2001.01268.x
  14. Soter, N.A. (1989). Morphology of atopic eczema. Allergy, 44, 16-19 https://doi.org/10.1111/j.1398-9995.1989.tb02449.x
  15. Vestergaard, C., Bang, K., Gesser, B., Yoneyama, H., Matsushima, K. and Larsen, C.G. (2000). A Th2 Chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. J. Invest. Dermatol., 115, 640-646 https://doi.org/10.1046/j.1523-1747.2000.00115.x

Cited by

  1. Preventive effects of a novel herbal mixture on atopic dermatitis-like skin lesions in BALB/C mice vol.19, pp.1, 2019, https://doi.org/10.1186/s12906-018-2426-z